ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 40 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,101 | +94.1% | 2,382 | +143.3% | 0.00% | – |
Q2 2023 | $7,264 | +242033.3% | 979 | +191.4% | 0.00% | – |
Q1 2023 | $3 | -40.0% | 336 | -22.9% | 0.00% | – |
Q4 2022 | $5 | -100.0% | 436 | -90.4% | 0.00% | -100.0% |
Q3 2022 | $33,000 | +17.9% | 4,565 | -21.4% | 0.00% | 0.0% |
Q2 2022 | $28,000 | +366.7% | 5,806 | +461.0% | 0.00% | – |
Q1 2022 | $6,000 | +20.0% | 1,035 | +14.7% | 0.00% | – |
Q4 2021 | $5,000 | +150.0% | 902 | +351.0% | 0.00% | – |
Q3 2021 | $2,000 | -93.3% | 200 | -94.7% | 0.00% | -100.0% |
Q2 2021 | $30,000 | +100.0% | 3,808 | +99.3% | 0.00% | – |
Q1 2021 | $15,000 | +7.1% | 1,911 | +29.0% | 0.00% | – |
Q3 2020 | $14,000 | – | 1,481 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
Virtu Financial LLC | 21,650 | $205 | 0.02% |
CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |